$9.200
-0.050 (-0.54%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ATRA por análisis de gráficos similares
Alphio's ATRA stock price prediction model matches the current Atara Biotherapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.48 (+3.00%). The 1-week path is $10.04 (+9.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Atara Biotherapeutics, Inc.?
Atara Biotherapeutics is currently priced at $9.20, with a forward P/E ratio of 3.63, suggesting it may be undervalued. However, the stock has seen a significant year-to-date decline of 48.23%, and insider selling has increased by 29504.54%, indicating potential risks. The recent upgrades from analysts suggest a cautious optimism, but the high insider selling and overall market sentiment lead to a recommendation to hold rather than buy.
ATRA cerró en $9.20 el Friday, tras bajar -0.54%
Atara Biotherapeutics, Inc. (ATRA) last closed at $9.2, losing -0.54%. These facts feed the 1-day and 1-week ATRA price prediction above.
Consenso de analistas
Atara Biotherapeutics, Inc. (ATRA): 4 comprar, 1 mantener, 1 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Atara Biotherapeutics, Inc. (ATRA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ATRA, ordenadas por similitud.
Análisis de estacionalidad de ATRA
Historically the probability of a positive August return for ATRA is 0.00%. December offers the highest probability of a positive month at 74.42%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ATRA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $15.35 | $19.66 | $26.52 | +113.71% |
| Sep 2026 | $11.04 | $13.37 | $22.90 | +45.31% |
| Oct 2026 | $14.53 | $22.10 | $23.17 | +140.24% |
| Nov 2026 | $9.89 | $14.45 | $20.17 | +57.03% |
| Dec 2026 | $8.33 | $15.01 | $19.93 | +63.20% |
En 2026, se proyecta que Atara Biotherapeutics, Inc. (ATRA) oscile entre $8.33 y $26.52.
Previsión mensual de Atara Biotherapeutics, Inc. para 2026
En Aug de 2026, se proyecta que Atara Biotherapeutics, Inc. promedie $19.66, con un mínimo de $15.35 y un máximo de $26.52.
En Sep de 2026, se proyecta que Atara Biotherapeutics, Inc. promedie $13.37, con un mínimo de $11.04 y un máximo de $22.90.
En Oct de 2026, se proyecta que Atara Biotherapeutics, Inc. promedie $22.10, con un mínimo de $14.53 y un máximo de $23.17.
En Nov de 2026, se proyecta que Atara Biotherapeutics, Inc. promedie $14.45, con un mínimo de $9.89 y un máximo de $20.17.
En Dec de 2026, se proyecta que Atara Biotherapeutics, Inc. promedie $15.01, con un mínimo de $8.33 y un máximo de $19.93.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.